A UK study reveals COVID-19 poses greater long-term cardiac and clotting risks in children compared to minimal vaccine ...
A proposed bill in South Carolina is stirring new controversy over the COVID-19 vaccine. If passed, the bill would require ...
A proposed bill in South Carolina is stirring new controversy over the COVID-19 vaccine. If passed, the bill would require ...
Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech. Have the good days finally come to an end ...
As a damning report finds all four UK governments failed to appreciate the scale of the threat posed by COVID-19 or the ...
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...
Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management , as it targets up to 10% revenue ...
With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...
The announcement that Pfizer was offloading a large block of shares initially created concern among investors. However, a closer examination reveals this is not a full separation. The US corporation ...
Two major studies published this month are raising new questions about potential health risks associated with the COVID-19 ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
The UK did “too little, too late,” in its early response to the coronavirus pandemic, leading to thousands of more deaths, the head of the UK Covid-19 Inquiry said as its latest findings were released ...